TTM
$21.3B
YoY change
-11.1%
5Y CAGR
+0.4%
Peak year (FY2025)
$23.9B
Cumulative EBITDA
$505B
EBITDA history chart for Procter & Gamble (PG) from 2017 to 2026
Latest: $21.3B
EBITDA growth chart for Procter & Gamble (PG) from 2017 to 2026
Latest: -11.1%
EBITDA history table for Procter & Gamble (PG) from 1986 to 2026
| FY2026 | $21.3B | -11.1% | -$2.67B | ||
| FY2025 | $23.9B | +5.9% | +$1.34B | ||
| FY2024 | $22.6B | +3.7% | +$811M | ||
| FY2023 | $21.8B | +2.5% | +$530M | ||
| FY2022 | $21.2B | +1.9% | +$389M | ||
| FY2021 | $20.9B | +8.0% | +$1.54B | ||
| FY2020 | $19.3B | +105.4% | +$9.91B | ||
| FY2019 | $9.4B | -43.6% | -$7.26B | ||
| FY2018 | $16.7B | +0.7% | +$124M | ||
| FY2017 | $16.5B | -2.2% | -$379M | ||
| FY2016 | $16.9B | +15.5% | +$2.27B | ||
| FY2015 | $14.7B | -15.6% | -$2.71B | ||
| FY2014 | $17.4B | -2.6% | -$469M | ||
| FY2013 | $17.8B | +8.0% | +$1.33B | ||
| FY2012 | $16.5B | -11.6% | -$2.17B | ||
| FY2011 | $18.7B | -1.4% | -$256M | ||
| FY2010 | $18.9B | +0.7% | +$125M | ||
| FY2009 | $18.8B | -7.2% | -$1.47B | ||
| FY2008 | $20.3B | +9.1% | +$1.69B | ||
| FY2007 | $18.6B | +17.0% | +$2.7B | ||
| FY2006 | $15.9B | +28.5% | +$3.52B | ||
| FY2005 | $12.4B | +11.1% | +$1.24B | ||
| FY2004 | $11.1B | +16.3% | +$1.56B | ||
| FY2003 | $9.56B | +14.2% | +$1.19B | ||
| FY2002 | $8.37B | +19.5% | +$1.36B | ||
| FY2001 | $7.01B | -14.0% | -$1.14B | ||
| FY2000 | $8.15B | -3.0% | -$256M | ||
| FY1999 | $8.4B | +9.8% | +$748M | ||
| FY1998 | $7.65B | +9.7% | +$678M | ||
| FY1997 | $6.98B | +13.0% | +$802M | ||
| FY1996 | $6.17B | +12.3% | +$676M | ||
| FY1995 | $5.5B | +16.6% | +$783M | ||
| FY1994 | $4.71B | +195.4% | +$3.12B | ||
| FY1993 | $1.6B | -59.3% | -$2.32B | ||
| FY1992 | $3.92B | +7.1% | +$260M | ||
| FY1991 | $3.66B | +15.7% | +$497M | ||
| FY1990 | $3.16B | +12.7% | +$355M | ||
| FY1989 | $2.81B | +12.6% | +$313M | ||
| FY1988 | $2.49B | +73.6% | +$1.06B | ||
| FY1987 | $1.44B | -20.0% | -$360M | ||
| FY1986 | $1.8B | — | — |
- FY2026$21.3B-11.1%
- FY2025$23.9B+5.9%
- FY2024$22.6B+3.7%
- FY2023$21.8B+2.5%
- FY2022$21.2B+1.9%
- FY2021$20.9B+8.0%
- FY2020$19.3B+105.4%
- FY2019$9.4B-43.6%
- FY2018$16.7B+0.7%
- FY2017$16.5B-2.2%
- FY2016$16.9B+15.5%
- FY2015$14.7B-15.6%
- FY2014$17.4B-2.6%
- FY2013$17.8B+8.0%
- FY2012$16.5B-11.6%
- FY2011$18.7B-1.4%
- FY2010$18.9B+0.7%
- FY2009$18.8B-7.2%
- FY2008$20.3B+9.1%
- FY2007$18.6B+17.0%
- FY2006$15.9B+28.5%
- FY2005$12.4B+11.1%
- FY2004$11.1B+16.3%
- FY2003$9.56B+14.2%
- FY2002$8.37B+19.5%
- FY2001$7.01B-14.0%
- FY2000$8.15B-3.0%
- FY1999$8.4B+9.8%
- FY1998$7.65B+9.7%
- FY1997$6.98B+13.0%
- FY1996$6.17B+12.3%
- FY1995$5.5B+16.6%
- FY1994$4.71B+195.4%
- FY1993$1.6B-59.3%
- FY1992$3.92B+7.1%
- FY1991$3.66B+15.7%
- FY1990$3.16B+12.7%
- FY1989$2.81B+12.6%
- FY1988$2.49B+73.6%
- FY1987$1.44B-20.0%
- FY1986$1.8B—
EBITDA values are taken from Procter & Gamble's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Procter & Gamble (PG)
According to Procter & Gamble's latest reported financial statements, the company's current EBITDA (TTM) is $21.3B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2026 fiscal year, Procter & Gamble (PG) reported EBITDA of $21.3B – declined 11.1% year-over-year.
Through 2021–2026 (5 years), Procter & Gamble EBITDA delivered a +0.4% annualised rate; with mixed annual results across the window.
Procter & Gamble EBITDA peaked at $23.9B in 2025; the latest annual figure is $21.3B in 2026 (11.1% below peak).
The record annual EBITDA stands at $23.9B, reached in 2025; the historical low of $1.44B was recorded in 1987.
Procter & Gamble EBITDA by Year
Procter & Gamble EBITDA 2026: $21.3B
Procter & Gamble posted EBITDA of $21.3B in 2026, declined 11.1% below 2025.
Procter & Gamble EBITDA 2025: $23.9B
In 2025, Procter & Gamble reported EBITDA of $23.9B, grew 5.9% from 2024. This figure represents the highest annual value in the available history.
Procter & Gamble EBITDA 2024: $22.6B
Procter & Gamble EBITDA in 2024 was $22.6B, edged up 3.7% from 2023.
Procter & Gamble EBITDA 2023: $21.8B
2023's EBITDA for Procter & Gamble came in at $21.8B, edged up 2.5% from 2022.
Procter & Gamble EBITDA 2022: $21.2B
Procter & Gamble EBITDA in 2022 was $21.2B.
See more financial history for Procter & Gamble (PG).
Sector peers by EBITDA
Consumer Defensive peers of Procter & Gamble (PG), ranked by their latest EBITDA
| $46.5B | |
| $18.7B | |
| $17.5B | |
| $15.5B | |
| $13.4B | |
| $10.8B | |
| $4.65B | |
| $2.6B |
- $46.5B
- $18.7B
- $15.5B
- $13.4B
- $10.8B
Frequently asked questions
Procter & Gamble (PG) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.42% TTM
- Dividend Profile2.94% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.